Fk506
FK506 is an immunosuppressant drug that functions as a calcineurin inhibitor. It acts by binding to the immunophilin FKBP12, forming a complex that inhibits the phosphatase activity of calcineurin, a key regulator of T-cell activation.
Lab products found in correlation
15 protocols using fk506
Preparation of Bioactive Lipid Solutions
Isolation and Activation of CD4 T Cells
Pharmacological inhibitors used were CGP-37157 (Tocris Bioscience, Ellisville, MO) (10 μM), CCCP (2 μM), rotenone (2 μM), antimycin (2 μM), Ru360 (10 μM), FK506 (InvivoGen, San Diego, CA) (10 nM), Stattic (10 μM).
Preparation of Stock Solutions
Fungal Strain Cultivation and Chemical Compound Preparation
Modulating CD8+ T Cell Responses
Isolation and Characterization of ADSC-derived Exosomes
Cell Viability Assay of Leukemia Cell Lines
Acute Cyclosporin-A and FK506 Effects
Antibodies and Reagents for Signaling
Inhibition of MEK1/2 Signaling Pathways
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!